{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:58:30Z","timestamp":1776747510052,"version":"3.51.2"},"reference-count":39,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2019]]},"DOI":"10.3164\/jcbn.18-103","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T22:36:16Z","timestamp":1551911776000},"page":"201-208","source":"Crossref","is-referenced-by-count":11,"title":["A ketogenic diet improves the prognosis in a mouse model of peritoneal dissemination without tumor regression"],"prefix":"10.3164","volume":"64","author":[{"given":"Eiji","family":"Kasumi","sequence":"first","affiliation":[{"name":"EN Otsuka Pharmaceutical Co., Ltd., R&D Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Sato","sequence":"additional","affiliation":[{"name":"EN Otsuka Pharmaceutical Co., Ltd., R&D Laboratories"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Coccolini F, Gheza F, Lotti M, et al. Peritoneal carcinomatosis. World J Gastroenterol 2013; 19: 6979\u20136994.","DOI":"10.3748\/wjg.v19.i41.6979"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol 2016; 22: 6829\u20136840.","DOI":"10.3748\/wjg.v22.i30.6829"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 2012; 30: 263\u2013267.","DOI":"10.1200\/JCO.2011.37.1039"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Nassour I, Polanco PM. Current management of peritoneal carcinomatosis from colorectal cancer: the role of cytoreductive surgery and hyperthermic peritoneal chemoperfusion. Curr Colorectal Cancer Rep 2017; 13: 144\u2013153.","DOI":"10.1007\/s11888-017-0361-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Helyer LK, Law CH, Butler M, Last LD, Smith AJ, Wright FC. Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer. Ann Surg Oncol 2007; 14: 1264\u20131271.","DOI":"10.1245\/s10434-006-9303-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22: 3284\u20133292.","DOI":"10.1200\/JCO.2004.10.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 309\u2013319.","DOI":"10.1016\/j.plefa.2003.09.007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Demetrius LA, Coy JF, Tuszynski JA. Cancer proliferation and therapy: the Warburg effect and quantum metabolism. Theor Biol Med Model 2010; 7: 2.","DOI":"10.1186\/1742-4682-7-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029\u20131033.","DOI":"10.1126\/science.1160809"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Klement RJ, Kammerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) 2011; 8: 75.","DOI":"10.1186\/1743-7075-8-75"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Dwarakanath BS. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose <i>in vitro<\/i>. J Cancer Res Ther 2009; 5 Suppl 1: S27\u2013S31.","DOI":"10.4103\/0973-1482.55137"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 E S, Yamamoto K, Sakamoto Y, et al. Intake of mulberry 1-deoxynojirimycin prevents colorectal cancer in mice. J Clin Biochem Nutr 2017; 61: 47\u201352.","DOI":"10.3164\/jcbn.16-94"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013; 339: 211\u2013214.","DOI":"10.1126\/science.1227166"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Eckschlager T, Plch J, Stiborova M, Hrabeta J. Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci 2017; 18: E1414.","DOI":"10.3390\/ijms18071414"},{"key":"15","unstructured":"15 Paster EV, Villines KA, Hickman DL. Endpoints for mouse abdominal tumor models: refinement of current criteria. Comp Med 2009; 59: 234\u2013241."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Sasawatari S, Okamura T, Kasumi E, et al. The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterology 2011; 140: 1513\u20131525.","DOI":"10.1053\/j.gastro.2011.01.041"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Jiang ZY, Qin SK, Yin XJ, Chen YL, Zhu L. Synergistic effects of Endostar combined with \u03b2-elemene on malignant ascites in a mouse model. Exp Ther Med 2012; 4: 277\u2013284.","DOI":"10.3892\/etm.2012.583"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Sangisetty SL, Miner TJ. Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 2012; 4: 87\u201395.","DOI":"10.4240\/wjgs.v4.i4.87"},{"key":"19","unstructured":"19 Luo JC, Toyoda M, Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor\/permeability factor neutralizing antibody. Cancer Res 1998; 58: 2594\u20132600."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983\u2013985.","DOI":"10.1126\/science.6823562"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yoshiji H, Kuriyama S, Hicklin DJ, et al. The vascular endothelial growth factor receptor KDR\/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model. Hepatology 2001; 33: 841\u2013847.","DOI":"10.1053\/jhep.2001.23312"},{"key":"22","unstructured":"22 Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830\u20135835."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Karadedou CT, Gomes AR, Chen J, et al. FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. Oncogene 2012; 31: 1845\u20131858.","DOI":"10.1038\/onc.2011.368"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Emerling BM, Weinberg F, Liu JL, Mak TW, Chandel NS. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc Natl Acad Sci U S A 2008; 105: 2622\u20132627.","DOI":"10.1073\/pnas.0706790105"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Poff AM, Ari C, Arnold P, Seyfried TN, D&apos;Agostino DP. Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer. Int J Cancer 2014; 135: 1711\u20131720.","DOI":"10.1002\/ijc.28809"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Poff AM, Ari C, Seyfried TN, D&apos;Agostino DP. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 2013; 8: e65522.","DOI":"10.1371\/journal.pone.0065522"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bonuccelli G, Tsirigos A, Whitaker-Menezes D, et al. Ketones and lactate \u201dfuel\u201d tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010; 9: 3506\u20133514.","DOI":"10.4161\/cc.9.17.12731"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 2011; 13: 213.","DOI":"10.1186\/bcr2892"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Al-Zoughbi W, Huang J, Paramasivan GS, et al. Tumor macroenvironment and metabolism. Semin Oncol 2014; 41: 281\u2013295.","DOI":"10.1053\/j.seminoncol.2014.02.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Terashima J, Tachikawa C, Kudo K, Habano W, Ozawa S. An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2. BMC Mol Biol 2013; 14: 27.","DOI":"10.1186\/1471-2199-14-27"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Park SH, Kim KW, Lee YS, et al. Hypoglycemia-induced VEGF expression is mediated by intracellular Ca2+ and protein kinase C signaling pathway in HepG2 human hepatoblastoma cells. Int J Mol Med 2001; 7: 91\u201396.","DOI":"10.3892\/ijmm.7.1.91"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Brownlow ML, Benner L, D&apos;Agostino D, Gordon MN, Morgan D. Ketogenic diet improves motor performance but not cognition in two mouse models of Alzheimer\u2019s pathology. PLoS One 2013; 8: e75713.","DOI":"10.1371\/journal.pone.0075713"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Beckett TL, Studzinski CM, Keller JN, Paul Murphy M, Niedowicz DM. A ketogenic diet improves motor performance but does not affect \u03b2-amyloid levels in a mouse model of Alzheimer\u2019s disease. Brain Res 2013; 1505: 61\u201367.","DOI":"10.1016\/j.brainres.2013.01.046"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria, and neurological diseases. J Lipid Res 2014; 55: 2211\u20132228.","DOI":"10.1194\/jlr.R048975"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Wang YX, Zhang CL, Yu RT, et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004; 2: e294.","DOI":"10.1371\/journal.pbio.0020294"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Schwartz K, Chang HT, Nikolai M, et al. Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature. Cancer Metab 2015; 3: 3.","DOI":"10.1186\/s40170-015-0129-1"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: II. Protocol of a randomised phase I study (KETOCOMP). Clin Nutr ESPEN 2016; 12: e1\u2013e6.","DOI":"10.1016\/j.clnesp.2015.11.001"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Sremanakova J, Sowerbutts AM, Burden S. A systematic review of the use of ketogenic diets in adult patients with cancer. J Hum Nutr Diet 2018; 31: 793\u2013802.","DOI":"10.1111\/jhn.12587"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Schroeder U, Himpe B, Pries R, Vonthein R, Nitsch S, Wollenberg B. Decline of lactate in tumor tissue after ketogenic diet: <i>in vivo<\/i> microdialysis study in patients with head and neck cancer. Nutr Cancer 2013; 65: 843\u2013849.","DOI":"10.1080\/01635581.2013.804579"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/64\/3\/64_18-103\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T03:40:42Z","timestamp":1556941242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/64\/3\/64_18-103\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.18-103","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}